1α,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent

Endocrinology

Volumn 138, Issue 8, 1997, Pages 3290-3298

  Zhao, Xiao Yan ^a   Ly, Lan H ^a   Peehl, Donna M ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; CALCITRIOL; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; ANILIDE; ANTIANDROGEN; BICALUTAMIDE; TRITIUM;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SECRETION; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIGAND BINDING; MALE; PRIORITY JOURNAL; PROSTATE CANCER; ANALYSIS OF VARIANCE; CELL CULTURE; CELL DIVISION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; NEOPLASM; NORTHERN BLOTTING; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SECRETION; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANDROGEN ANTAGONISTS; ANDROGENS; ANILIDES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCITRIOL; CELL DIVISION; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRITIUM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 85047675514     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.8.5328     Document Type: Article

References (34)

1. Holick MF 1989 Vitamin D: biosynthesis, metabolism, and mode of action. In: DeGroot LJ (ed) Endocrinology. Grune and Stratton, New York, pp 902-926
2. Feldman D, Malloy PJ, Gross C 1996 Vitamin D: metabolism and action. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, San Diego, pp 205-235
3. Suda T, Miyaura C, Abe E, Kuroki T 1986 Modulation of cell differentiation, immune response and tumor promotion by vitamin D compounds. In: Peck W (ed) Bone and Mineral Research. Elsevier, Amsterdam, pp 1-49
4. Pols HAP, Birkenhager JC, Foekens JA, Van Leeuwen JPTM 1990 Vitamin D: a modulator of cell proliferation and differentiation. J Steroid Biochem 37:873-876
5. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 132:1952-1960
6. 3 on primary cultures of human prostatic cells. Cancer Res 54:805-810
7. Skowronski RJ, Peehl DM, Feldman D 1995 Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3. Endocrinology 136:20-26
8. Miller GJ, Stapleton GE, Ferrara JA, Lucia MS, Pfister S, Hedlund TE, Upadhya P 1992 The human prostatic carcinoma cell line LNCaP expresses biologically active, specific receptors for 13. Cancer Res 52:515-520
9. Schwartz GG, Oeler TA, Uskokovic MR, Bahnson RR 1994 Human prostate cancer cells: inhibition of proliferation by vitamin D analogs. Anticancer Res 14:1077-1081
10. Hedlund TE, Moffatt KA, Miller GJ 1996 Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway. Endocrinology 137:1554-1561
11. 3 and 9-cis retinoic acid act synergistically to inhibit growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology 138:1491-1497
12. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
13. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298
14. Chang C, Kokontis J, Liao S 1988 Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324-326
15. Lubahn DB, Joseph DR, Sullivan PM, Willard HF, French FS, Wilson EM 1988 Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science 240:327-330
16. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 240:889-895
17. Mangelsdorf DJ, Thummel C, Miguel B, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
18. Riegman PHJ, Vlietstra RJ, van der Korput JAGM, Brinkman AO, Trapman J 1991 The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 5:1921-1930
19. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR 1996 Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 271:7043-7051
20. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu M, Mirand EA, Murphy GP 1983 LNCaP model of human prostatic carcinoma. Cancer Res 43:1809-1818
21. Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM 1995 Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone. Endocrinology 136:796-803
22. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, Brinkmann AO, Mulder E 1992 The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669
23. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E 1992 Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31:2393-2399
24. Burton K 1956 A study of conditions and mechanisms of the diphenyl amine colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323
25. Malloy PJ, Hochberg Z, Pike JW, Feldman D 1989 Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent ricketts, type II. J Clin Endocrinol Metab 68:263-269
26. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254
27. 3 in cultured mouse osteoblast-like cells-modulation by changes in receptor level. J Cell Physiol 126:21-28
28. 3 receptor gene expression in cultured cells by serum and growth factors. J Bone Miner Res 6:1099-1107
29. Janssen PJ, Brinkmann AO, Boersma WJ, Van der Kwast TH 1994 Immunohistochemical detection of the androgen receptor with monoclonal antibody F39.4 in routinely processed, paraffin-embedded human tissues after microwave pre-treatment. J Histochem Cytochem 42:1169-1175
30. Mizokami A, Yeh SY, Chang C 1994 Identification of 3′,5′-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. Mol Endocrinol 8:77-88
31. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478
32. Esquenet M, Swinnen JV, Heyns W, Verhoeven G 1996 Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1 alpha, 25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate 28:182-94
33. Hsieh TY, Ng CY, Mallouh C, Tazaki H, Wu JM 1996 Regulation of growth, PSA/PAP and androgen receptor expression by 1 alpha, 25-dihydroxyvitamin D3 in the androgen-dependent LNCaP cells. Biochem Biophys Res Commun 223:141-146
34. Quarmby VE, Yarbrough WG, Lubahn DB, French FS, Wilson EM 1990 Autologous down-regulation of androgen receptor messenger ribonucleic acid. Mol Endocrinol 4:22-28